AFO
ABBV icon

Arrowroot Family Office’s AbbVie ABBV Stock Holding History

Arrowroot Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
+1,059
New +$235K 0.08% 146
2025
Q4 		– Sell
-1,375
Closed -$318K – 141
2025
Q3 		$318K Buy
+1,375
New +$280K 0.13% 111
2024
Q4 		$204K Buy
+1,146
New +$211K 0.11% 129

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowroot Family Office's ABBV Position: Q1 2026 in Review

Arrowroot Family Office opened a new position in AbbVie (ABBV) in Q1 2026: 1,059 shares worth $230K. The stake represents 0.08% of the portfolio and ranks #146 among its holdings. This is a return to the name: Arrowroot Family Office previously reported a position in ABBV as recently as Q3 2025.

Arrowroot Family Office first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. The position peaked at $318K in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Arrowroot Family Office held 1,059 shares of AbbVie worth $230K as of Q1 2026.
  • AbbVie was a new Arrowroot Family Office position in Q1 2026.
  • AbbVie made up 0.08% of Arrowroot Family Office's portfolio in Q1 2026, its #146 holding.
  • Arrowroot Family Office first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • Arrowroot Family Office's AbbVie position peaked at $318K in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Arrowroot Family Office's 13F filing for Q1 2026, filed 14 May 2026.